Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: BEVACIZUMAB, . Treffer: 31

2017

Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Anticancer Res. 2017; 37(5):2683-2691
Web of Science PubMed FullText FullText_MUG

 

Palkovits, S; Seidel, G; Pertl, L; Malle, EM; Hausberger, S; Makk, J; Singer, C; Osterholt, J; Herzog, SA; Haas, A; Weger, M MACULAR CHOROIDAL VOLUME CHANGES AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Retina. 2017; 37(12):2262-2268
Web of Science PubMed FullText FullText_MUG

 

2016

Smretschnig, E; Hagen, S; Glittenberg, C; Ristl, R; Krebs, I; Binder, S; Ansari-Shahrezaei, S Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy.
Eye (Lond). 2016; 30(6):805-811 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Svejda, B; Muschitz, Ch; Gruber, R; Brandtner, Ch; Svejda, Ch; Gasser, RW; Santler, G; Dimai, HP [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Wien Med Wochenschr. 2016; 166(1-2):68-74
Web of Science PubMed FullText FullText_MUG

 

2015

Benesch, M; Lackner, H; Pilhatsch, A; Gürtl-Lackner, B; Schwinger, W; Urban, C Long-term Remission in a Female With Multiple Relapsed Juvenile Granulosa Cell Tumor.
J Pediatr Hematol Oncol. 2015; 37(8):e486-e489 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Riss, D; Burian, M; Wolf, A; Kranebitter, V; Kaider, A; Arnoldner, C Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial.
Head Neck. 2015; 37(6):783-787
Web of Science PubMed FullText FullText_MUG

 

2014

Schwarzenberg, J; Czernin, J; Cloughesy, TF; Ellingson, BM; Pope, WB; Grogan, T; Elashoff, D; Geist, C; Silverman, DH; Phelps, ME; Chen, W Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.
Clin Cancer Res. 2014; 20(13):3550-3559 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Smolle, E; Taucher, V; Haybaeck, J Malignant ascites in ovarian cancer and the role of targeted therapeutics.
Anticancer Res. 2014; 34(4):1553-1561
Web of Science PubMed

 

Stiegelbauer, V; Perakis, S; Deutsch, A; Ling, H; Gerger, A; Pichler, M MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
World J Gastroenterol. 2014; 20(33):11727-11735 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2013

Krebs, I; Glittenberg, C; Ansari-Shahrezaei, S; Hagen, S; Steiner, I; Binder, S Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration.
Br J Ophthalmol. 2013; 97(11):1443-1446
Web of Science PubMed FullText FullText_MUG

 

Krebs, I; Schmetterer, L; Boltz, A; Told, R; Vécsei-Marlovits, V; Egger, S; Schönherr, U; Haas, A; Ansari-Shahrezaei, S; Binder, S; MANTA Research Group A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration.
Br J Ophthalmol. 2013; 97(3):266-271
Web of Science PubMed FullText FullText_MUG

 

Michelitsch, M; Gasser-Steiner, V; Gasser-Steiner, P; The incidence and treatment of diabetic macular edema at the University Eye-Clinic Graz for a period of 2 years.
SPEKTRUM AUGENHEILKD. 2013; 27(5): 234-238.
Web of Science FullText FullText_MUG

 

Pansy, J; Fritsch, P; Sovinz, P; Lackner, H; Schwinger, W; Urban, C; Benesch, M Add-on-therapy with bevacizumab in children and adolescents with poor prognosis non-CNS solid tumors.
Anticancer Drugs. 2013; 24(2):198-203
Web of Science PubMed FullText FullText_MUG

 

Smolle, E; Taucher, V; Pichler, M; Petru, E; Lax, S; Haybaeck, J Targeting signaling pathways in epithelial ovarian cancer.
Int J Mol Sci. 2013; 14(5):9536-9555 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Strenger, V; Lackner, H; Mayer, R; Sminia, P; Sovinz, P; Mokry, M; Pilhatsch, A; Benesch, M; Schwinger, W; Seidel, M; Sperl, D; Schmidt, S; Urban, C Incidence and clinical course of radionecrosis in children with brain tumors. A 20-year longitudinal observational study.
Strahlenther Onkol. 2013; 189(9):759-764
Web of Science PubMed FullText FullText_MUG

 

2012

Dunavoelgyi, R; Sacu, S; Eibenberger, K; Palkovits, S; Leydolt, C; Pruente, C; Schmidt-Erfurth, U Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results.
Retina. 2012; 32(8): 1471-1479.
Web of Science PubMed FullText FullText_MUG

 

Grunewald, TGP; Greulich, N; Kontny, U; Fruhwald, M; Rutkowski, S; Kordes, U; Scheurlen, W; Schmidt, W; Stachel, D; Metzler, M; Mittler, U; Graf, N; Benesch, M; Burdach, S Targeted Therapeutics in Treatment of Children and Young Adults with Solid Tumors: an Expert Survey and Review of the Literature
Klin Padiatr. 2012; 224(3):124-131
Web of Science PubMed FullText FullText_MUG

 

Schwarzenberg, J; Czernin, J; Cloughesy, TF; Ellingson, BM; Pope, WB; Geist, C; Dahlbom, M; Silverman, DH; Satyamurthy, N; Phelps, ME; Chen, W 3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab.
J Nucl Med. 2012; 53(1):29-36 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Tarmann, L; Wedrich, A; Haas, A; Berghold, A; Kresse, A; Vajda, C; Maier, R; Limited vitrectomy with intravitreal bevacizumab, rt-PA and gas for submacular hemorrhage due to age-related macular degeneration.
SPEKTRUM AUGENHEILKD. 2012; 26(4): 197-201.
Web of Science FullText FullText_MUG

 

2011

Gerger, A; Labonte, M; Lenz, HJ Molecular predictors of response to antiangiogenesis therapies.
Cancer J. 2011; 17(2):134-141
Web of Science PubMed FullText FullText_MUG

 

Schmid-Kubista, KE; Krebs, I; Ansari-Shahrezaei, S; Haas, P; Hagen, S; Binder, S Comparing treatment of neovascular age-related macular degeneration with sequential intravitreal Avastin and Macugen versus intravitreal mono-therapy--a pilot study.
Curr Eye Res. 2011; 36(10):958-963
Web of Science PubMed FullText FullText_MUG

 

2010

Moussa, S; Ansari-Shahrezaei, S; Smretschnig, E; Hagen, S; Steindl-Kuscher, K; Krebs, I; Binder, S Contrast sensitivity after intravitreal antivascular endothelial growth factor therapy for myopic choroidal neovascularization.
Graefes Arch Clin Exp Ophthalmol. 2010; 248(8):1087-1090
Web of Science PubMed FullText FullText_MUG

 

Prager, GW; Lackner, EM; Krauth, MT; Unseld, M; Poettler, M; Laffer, S; Cerny-Reiterer, S; Lamm, W; Kornek, GV; Binder, BR; Zielinski, CC; Valent, P Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.
Mol Oncol. 2010; 4(2): 150-160. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zhang, W; Azuma, M; Lurje, G; Gordon, MA; Yang, D; Pohl, A; Ning, Y; Bohanes, P; Gerger, A; Winder, T; Hollywood, E; Danenberg, KD; Saltz, L; Lenz, HJ Molecular Predictors of Combination Targeted Therapies (Cetuximab, Bevacizumab) in Irinotecan-Refractory Colorectal Cancer (BOND-2 Study).
Anticancer Res. 2010; 30(10):4209-4217
Web of Science PubMed

 

2009

Weiss, K; Steinbrugger, I; Weger, M; Ardjomand, N; Maier, R; Wegscheider, BJ; Wedrich, A; El-Shabrawi, Y Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab.
Eye. 2009; 23(9): 1812-1818. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2008

Benesch, M; Windelberg, M; Sauseng, W; Witt, V; Fleischhack, G; Lackner, H; Gadner, H; Bode, U; Urban, C Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumors.
Ann Oncol. 2008; 19(4): 807-813. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kook, D; Wolf, A; Kreutzer, T; Neubauer, A; Strauss, R; Ulbig, M; Kampik, A; Haritoglou, C Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Retina. 2008; 28(8):1053-1060
Web of Science PubMed FullText FullText_MUG

 

Krebs, I; Ansari-Shahrezaei, S; Goll, A; Binder, S Activity of neovascular lesions treated with bevacizumab: comparison between optical coherence tomography and fluorescein angiography.
Graefes Arch Clin Exp Ophthalmol. 2008; 246(6):811-815
Web of Science PubMed FullText FullText_MUG

 

2007

D'Angelica, M; Kornprat, P; Gonen, M; Chung, KY; Jarnagin, WR; DeMatteo, RP; Fong, Y; Kemeny, N; Blumgart, LH; Saltz, LB Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study.
Ann Surg Oncol. 2007; 14(2):759-765
Web of Science PubMed FullText FullText_MUG

 

Priglinger, SG; Wolf, AH; Kreutzer, TC; Kook, D; Hofer, A; Strauss, RW; Alge, CS; Kunze, C; Haritoglou, C; Kampik, A Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial.
Retina. 2007; 27(8):1004-1012
Web of Science PubMed FullText FullText_MUG

 

Terheyden, P; Hofmann, MA; Weininger, M; Brocker, EB; Becker, JC Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma.
J Cancer Res Clin Oncol. 2007; 133(11):897-901 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

© Meduni Graz Impressum